Aeterna Zentaris is a biotechnology business based in Canada. Aeterna Zentaris shares (AEZS) are listed on the Toronto Stock Exchange (TSX) and all prices are listed in Canadian Dollars.
Our top picks for where to buy Aeterna Zentaris stock
How to buy Aeterna Zentaris stock
- Choose a stock trading platform. Compare investment platforms.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AEZS. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Aeterna Zentaris stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
Aeterna Zentaris stock price (Toronto Stock Exchange (TSX): AEZS)
Use our graph to track the performance of AEZS stocks over time.Aeterna Zentaris stocks at a glance
52-week range | C$4.64 - C$12.50 |
---|---|
50-day moving average | C$7.81 |
200-day moving average | C$7.33 |
Wall St. target price | C$4.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | C$-3.18 |
Is it a good time to buy Aeterna Zentaris stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aeterna Zentaris financials
Revenue TTM | C$2.4 million |
---|---|
Gross profit TTM | C$5.2 million |
Return on assets TTM | -29.96% |
Return on equity TTM | -81.71% |
Profit margin | 0% |
Book value | C$10.68 |
Market Capitalization | C$25.4 million |
EBITDA | C$-19,891,000 |
TTM: trailing 12 months
Aeterna Zentaris stock dividends
We're not expecting Aeterna Zentaris to pay a dividend over the next 12 months.
Have Aeterna Zentaris's stocks ever split?
Aeterna Zentaris's stocks were split on a 0.0236:1 basis on 6 June 2024 . So if you had owned 1 share the day before before the split, the next day you'd have owned 0.0236 shares. This wouldn't directly have changed the overall worth of your Aeterna Zentaris stocks – just the quantity. However, indirectly, the new 4137.3% higher stock price could have impacted the market appetite for Aeterna Zentaris stocks, which in turn could have impacted Aeterna Zentaris's stock price.
Aeterna Zentaris stock price volatility
Over the last 12 months, Aeterna Zentaris's stocks have ranged in value from as little as C$4.64 up to C$12.5. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (TO average) beta is 1, while Aeterna Zentaris's is 2.257. This would suggest that Aeterna Zentaris's stocks are significantly more volatile than the average for this exchange and represent a higher risk.
Aeterna Zentaris overview
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment of chronic hypoparathyroidism; and AEZS-130 that is in preclinical trial for the treatment of amyotrophic lateral sclerosis. The company also has a license and research agreement with University of Wuerzburg to develop, manufacture, and commercialize AIM biologicals for the treatment of neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease. In addition, it has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria Eood for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults; as well as The University of Sheffield, the United Kingdom for the development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of chronic hypoparathyroidism.
Frequently asked questions
What percentage of Aeterna Zentaris is owned by insiders or institutions?Currently 1.321% of Aeterna Zentaris stocks are held by insiders and 5.213% by institutions. When does the fiscal year end for Aeterna Zentaris?
Aeterna Zentaris's fiscal year ends in December. Where is Aeterna Zentaris based?
Aeterna Zentaris's address is: 222 Bay Street, Toronto, Canada, M5K 1E7 What is Aeterna Zentaris's ISIN number?
Aeterna Zentaris's international securities identification number is: CA0079754028
More on investing

What are the best stocks for beginners with little money to invest?
Want to dive into investing but don’t have much to spend? Take a look at these types of stocks.
Read more…
Meme stocks: What they are and examples of popular stocks
Meme stocks can produce large gains in short periods, but the stocks are volatile.
Read more…
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…More guides on Finder
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Best stocks to buy right now in Canada
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
-
5 Best ETFs in Canada for 2025
Looing for the best performing ETF in Canada? Explore the best Canadian ETFs on the TSX for dividend, REIT, bond investing and more.
-
4 Best US ETFs for 2025
Looing for the best US ETF? Explore the best US ETFs, including top US dividend and Nasdaq funds.
-
10 best stock trading platforms and apps in Canada for 2025
Whether you’re a new or experienced investor, these are the best stock trading platforms and apps in Canada.
-
How to buy US stocks in Canada
Buying US stocks in Canada is easier than you think. Find out how to buy US stocks in 4 simple steps.
-
How to invest in the S&P 500 in Canada
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
-
BMO InvestorLine review
Check out the pros and cons of BMO’s self-directed trading platform in our InvestorLine review.
-
How to trade options in Canada
What is options trading and are options better than stocks? Learn how options trading in Canada works.
-
How to buy stocks in Canada
Want to know how to buy and sell stocks in Canada? Find out what you need to know in this simple, step-by-step guide.